Product Details
Zytux Rituximab Injection 500mg/50ml Price in Pakistan | SalePakistan.com.pk
Zytux Rituximab Injection 500mg/50ml contains rituximab, a monoclonal antibody that targets the CD20 protein on B lymphocytes. Rituximab is used under specialist medical supervision for certain blood cancers and selected autoimmune conditions. Zytux 500mg/50ml is supplied as a concentrated solution intended for intravenous infusion after dilution.
Benefits / Uses
- Used in the treatment of certain B-cell non-Hodgkin lymphomas.
- Used in selected chronic lymphocytic leukemia (CLL) treatment regimens.
- May be prescribed for certain autoimmune and inflammatory disorders.
- Targets CD20-positive B cells, helping reduce these cells as part of the prescribed treatment plan.
Specifications
| Specification | Details |
|---|---|
| Brand Name | Zytux |
| Generic Name | Rituximab |
| Strength | 500mg |
| Volume | 50ml |
| Concentration | 10mg/ml |
| Dosage Form | Concentrate for solution for infusion |
| Route | Intravenous (IV) infusion |
| Product Type | Prescription biologic medicine |
| Pack | 1 × 50ml vial |
The 500mg/50ml presentation corresponds to a 10mg/ml rituximab solution for IV administration.
How To Use
Zytux should only be administered by a qualified healthcare professional according to the prescribing physician's treatment protocol. The concentrate is diluted before IV infusion; the dose, infusion schedule and duration depend on the patient's diagnosis and treatment regimen.
Do not self-inject or administer at home. Patients should be monitored by healthcare professionals during treatment because rituximab can cause serious infusion-related and other adverse reactions.
Why Choose Zytux?
- Contains rituximab, an established anti-CD20 monoclonal antibody.
- Available in the convenient 500mg/50ml vial presentation.
- Intended for use under specialist supervision in appropriate treatment protocols.
- Suitable for healthcare facilities requiring a rituximab IV infusion presentation.
Important: Zytux is a prescription medicine. The treating specialist should determine whether rituximab is appropriate, including the dose and treatment schedule. Always verify the vial, batch number, expiry date, storage conditions and authenticity before administration.
